海王生物：拟2.48亿元转让河南东森100%股权

Group 1 - The core point of the article is that Haiwang Bio (000078.SZ) announced the transfer of 100% equity of Henan Dongsen Pharmaceutical Co., Ltd. from its subsidiary Henan Haiwang Group to Henan Huicheng Medical Technology Co., Ltd. for a transaction price of 248.0079 million yuan [1] - As of the end of September 2025, Henan Dongsen's net assets are reported to be 327.4112 million yuan, with a net profit of 18.8409 million yuan for the first nine months of 2025 [1] - The company has provided a guarantee balance of 478.1216 million yuan for Henan Dongsen, which needs to be released within six months after the transaction completion [1]